Emgality and Lacrimation increased - a phase IV clinical study of FDA data

Summary:

Lacrimation increased is reported as a side effect among people who take Emgality (galcanezumab-gnlm), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Pepcid, and have Migraine.

The phase IV clinical study analyzes which people have Lacrimation increased when taking Emgality. It is created by eHealthMe based on reports of 24,623 people who have side effects when taking Emgality from the FDA, and is updated regularly.

What is Emgality?

Emgality has active ingredients of galcanezumab-gnlm. eHealthMe is studying from 24,702 Emgality users. Check the latest studies of Emgality.

What is Lacrimation increased?

Lacrimation increased is found to be associated with 1,340 drugs and 1,798 conditions by eHealthMe. Check the latest studies of Lacrimation increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

24,623 people reported to have side effects when taking Emgality.
Among them, 13 people (0.05%) have Lacrimation increased.

Could Emgality cause Lacrimation increased?

Among these 13 people:

How long have people been on Emgality when they have Lacrimation increased? *

What is the gender of people who have Lacrimation increased when taking Emgality? *

female: 92.31 %
male: 7.69 %

What is the age of people who have Lacrimation increased when taking Emgality? *

What are other drugs people take besides Emgality? *

What are other side effects people have besides Lacrimation increased? *

Headache (pain in head): 3 people, 23.08%
Pain: 3 people, 23.08%
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 2 people, 15.38%
Swelling Face: 2 people, 15.38%
Stress And Anxiety: 2 people, 15.38%
Rashes (redness): 2 people, 15.38%
Cough: 2 people, 15.38%
Ear Pain: 2 people, 15.38%
Nausea (feeling of having an urge to vomit): 2 people, 15.38%
Eye Pain: 2 people, 15.38%

What are the existing conditions these people have? *

Migraine (headache): 8 people, 61.54%
Systemic Mastocytosis (a condition caused by the accumulation of mast cells in more than one part of the body): 1 person, 7.69%
Insomnia (sleeplessness): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Emgality and have Lacrimation increased?

- Check whether Lacrimation increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Emgality:

Emgality (24,702 reports)

Browse all side effects of Emgality:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lacrimation increased:

Lacrimation increased (1,340 drugs)

Browse all the conditions that are associated with Lacrimation increased:

Lacrimation increased (1,798 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on galcanezumab-gnlm (the active ingredients of Emgality) and Emgality (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.